Scientists may have pinpointed a primary cause of lupus, a chronic autoimmune disease. Researchers from Northwestern Medicine in Chicago and Brigham and Women’s Hospital in Boston claim they have ...

Three patients in the UK have received a”groundbreaking” treatment for lupus on the NHS, which experts hope could eradicate the need for lifelong drugs. Until now, CAR T-cell therapy in the UK has ...

The total market size of systemic lupus erythematosus is expected to increase in the 7MM during the forecast period, driven by ongoing clinical research of therapies such as nipocalimab (Johnson & ...

More than 50% of patients with systemic lupus erythematosus (SLE) experienced flare and nearly 50% had persistently active disease, whereas some had persistently active disease without flare. Both ...

Lupus is an autoimmune disease; the body’s immune system attacks healthy cells leading to pain, fever, rashes, organ damage and other symptoms. The Lupus Foundation of America estimates more than 5 ...

Scientists have found the clearest evidence yet that Epstein-Barr virus (EBV) – which nearly all of us carry for life – is directly responsible for hijacking our immune system's cells to cause lupus, ...

In further Phase 3 TULIP trial research of anifrolumab, commonly known as SAPHNELO®, people with lupus taking the drug experienced earlier, more frequent, and more prolonged and sustained low lupus ...

Please provide your email address to receive an email when new articles are posted on . Chimeric antigen receptor T-cell therapy improves not only lupus disease activity but also other related ...

Fatigue, pain, swelling, rashes and hair loss are just some of the symptoms that affect people with lupus, a chronic autoimmune disease in which the immune system attacks healthy tissue. Some 1.5 ...